Lacosamide Stada

Lacosamide, the active ingredient in Lacosamide Stada, is an anticonvulsant presented as an oral tablet for oral use. It is indicated as adjunctive therapy for partial‑onset seizures in patients with epilepsy, helping to reduce seizure frequency when added to existing antiepileptic regimens.

GNH USA supplies Lacosamide Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple regions globally.

Lacosamide is an antiepileptic drug used as adjunctive therapy for partial‑onset seizures in epilepsy, aiming to lower seizure frequency when combined with other antiepileptic medications.

- Partial‑onset seizures: reduces seizure frequency as an add‑on treatment. - Focal epilepsy: improves overall seizure control when other agents are insufficient. - Refractory focal seizures: offers an alternative mechanism for patients not responding to traditional sodium‑channel blockers.

Lacosamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: mild to moderate stomach upset. - Fatigue: increased tiredness or lack of energy. - Headache: mild to moderate pain in the head region.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm, including PR‑interval prolongation. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal ideation: thoughts of self‑harm requiring immediate medical attention.

When prescribing Lacosamide, clinicians should consider several safety aspects.

- Renal impairment: dose may need adjustment based on kidney function. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Concomitant CNS depressants: increased risk of sedation and respiratory depression. - Pregnancy: potential risks are unknown; discuss benefits and risks with the patient. - Discontinuation: avoid abrupt stopping to prevent seizure worsening. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lacosamide can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Carbamazepine: may lower lacosamide plasma concentrations. - Phenytoin: can reduce lacosamide effectiveness. - Rifampin: induces metabolism, decreasing lacosamide levels.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, opioids): may enhance sedation. - Serotonergic agents (e.g., SSRIs, tramadol): risk of serotonin syndrome. - Antihypertensives: possible additive hypotensive effect.